CAPRICOR THERAPEUTICS, INC. — Director's Dealing 2009

Jul 23, 2009

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Nile Therapeutics, Inc. (NLTX)
CIK: 0001133869
Period of Report: 2009-07-21

Reporting Person: SCHAFER GREGORY W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2009-07-21	Stock Option (Right to Buy)	$1.77	A	80000	Acquired	2019-07-21	Common Stock (80000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	100	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$4.50	2018-01-25	Common Stock (60000)	60000	Direct
Stock Option (Right to Buy)	$.93	2018-12-22	Common Stock (35000)	35000	Direct

Footnotes

F1: The shares subject to the option vest in three equal installments on Janaury 25, 2009, January 25, 2010 and January 25, 2011.